Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Gaičiūnas, , Gabrielius,
DOB: 19-MAY-1948 (Age: 77)
Gender: male
Address:
5951 Monika Rapid
97190 Poškaton (Lithuania)
ID: 5711-320329-3 (ECI)
Report
Date: 16-DEC-2016
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Dr. Tomas Bakas
182 Savanorių pr.
LT-91200 Klaipėda (Lithuania)
Specimen
Collected: 16-DEC-2016

Chemistry

Test 16-DEC-2016 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 4.0 L 4.6 - 6.4 %
Glucose [Mass/volume] in Blood 94.6 70 - 110 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.4 7 - 43 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 139.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.4 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 101.5 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.6 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured parameters are within normal limits except for a mildly decreased HbA1c (4.0%), which may suggest recent hypoglycemia, low average glucose, or possible analytical/physiological variation. No evidence of renal, electrolyte, or metabolic disturbances. Correlate HbA1c finding with clinical context and consider repeat if clinically indicated.